Hugel Participates in Thailand’s Largest Dermatology Conference to Strengthen Southeast Asian Market Expansion

by Kwak Minjae

Published 13 Mar.2026 08:53(KST)

Sharing Clinical Experiences and Procedural Expertise with 'Revolax'

Hugel, a global total medical aesthetics company, participated in the largest dermatology conference in Thailand to introduce its botulinum toxin and hyaluronic acid (HA) filler products to local medical professionals, aiming to expand its presence in the Southeast Asian market.

Hugel is introducing the HA filler "Revolax" through a roundtable at the largest dermatology conference in Thailand. Hugel

Hugel announced on March 13 that it participated in the annual scientific meeting of the Dermatological Society of Thailand (DST) held at Centara Grand at CentralWorld in Bangkok from March 11 to 13, together with its local partners. The DST annual scientific meeting, marking its 50th session this year, is the largest dermatology conference in Thailand.

During the event, Hugel promoted its botulinum toxin product 'Botulax' (marketed as 'S-tox' in Thailand) and its HA filler 'The Chaeum' (exported under the name 'Revolax'). In particular, Hugel organized a dedicated academic program focusing on Revolax.

On March 10, the day before the official opening, the company held the 'Revolax Experts Private Roundtable', where Dr. Lior Hanan, a French plastic surgeon, presented real-world application cases and clinical considerations. At a lunch symposium on March 11, Dr. Pitchaya Maniprasopchok, a Thai dermatologist, shared clinical data and procedural expertise based on Thai patients.

A Hugel representative stated, "Thailand is the largest aesthetics market in Southeast Asia and a key country where global companies are focusing their efforts. By participating in a conference attended by most of the country's dermatologists, we were able to strengthen our academic foundation and communicate directly with medical professionals."